Castleview Partners »

Klotho Neurosciences shares owned by Castleview Partners

Quarter-by-quarter ownership of Klotho Neurosciences (GRML) shares owned by Castleview Partners from 13F filings

Historical chart of Castleview Partners investment in Klotho Neurosciences

Tip: Access up to 7 years of quarterly data

All positions including Klotho Neurosciences held by Castleview Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Klotho Neurosciences by Castleview Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.3k 10k 0.33

More positions owned by Castleview Partners

Valued Advisers Tr Regan Fltg Rate (MBSF)
Advisor Managed Portfolios Regan Fixed Rate (MBSX)
ConocoPhillips (COP)
Apple (AAPL)
Tesla Motors (TSLA)
Managed Portfolio Series Leuthold Select (LST)
Bristol Myers Squibb (BMY)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Advisors Inner Circle Fd Ii Pmv Adaptive Rsk (ARP)
Home Depot (HD)
Kkr & Co (KKR)
Vaneck Etf Trust Real Assets Etf (RAAX)
Fidelity Covington Trust High Divid Etf (FDVV)
Amgen (AMGN)
UnitedHealth (UNH)

View all positions for Castleview Partners

Top funds holding Klotho Neurosciences

Meteora Capital
UBS Group
Geode Capital Management
Vanguard Group
Vanguard Capital Management
Renaissance Technologies
Vanguard Fiduciary Trust
Brummer Multi-Strategy AB
Two Sigma Securities
Am Investment Strategies
State Street Corporation
XTX Topco
BlackRock
Morgan Stanley
Northern Trust

View all funds holding Klotho Neurosciences